European Graves’ Disease Market: Global Size, Share, Industry Trends, Research and Forecast 2019-2025


Posted March 11, 2020 by orionmarketresearch

European Graves’ disease Market Size, Share & Trends Analysis Report by Diagnosis, by Treatment - Forecast Period 2019-2025

 
European Graves’ disease market is growing at a CAGR of around 4.4% during the forecast period. Europe consists of numerous key economies including the UK, Germany, Spain, Italy, and Russia among various others which play a significant role in the development of the Grave’s market in the region. The key reason which is promoting the growth of the market in Europe is the changing lifestyle and higher prevalence of smoking in the countries of European region is expected to promote the prevalence of Grave’s disease, thereby creating opportunity for the growth of the European Graves’ diseases market over the forecast period.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/european-graves-disease-market

Europe is the well-established region comprises of few of the largest economies of the world. The region has established healthcare industry due to growing funding in the healthcare R&D and awareness programs. This directly impacts the funding and awareness about thyroid related diseases such as Grave’s disease, thyroid cancer and others. Presence of the key market players such as Apitope technology Ltd., GlaxoSmithKline PLC and others is also affecting the growth of the market. Growing prevalence of type-1 diabetes is one of the major factors contributing significantly in the European Grave’s disease market.

A full report of European Graves’ Disease Market is available at: https://www.omrglobal.com/industry-reports/european-graves-disease-market

Further, Apitope International NV is a biotechnology company, based in Belgium, that manufactures and markets commercialized products for autoimmune disease. The company provides product candidate ATX-GD-59 that is a disease-modifying treatment for Grave’s disease. ATX-GD-59 is presently being assessed in a Phase I study in patients and the company plans to initiate a Phase II study in the first quarter of 2019. Thus, the presence of the market players strengthens the domestic presence and also aids in the growth of the European Graves’ disease market.

European Graves’ Disease Market – Segmentation

by Diagnosis

• Ultrasound
• Imaging Tests
• Radioactive Iodine Uptake
• Blood Sample

by Treatment

• Anti- Thyroid Medication
• Radioactive Iodine Therapy
• Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-graves-disease-market

Global Airport Security Systems Market – Segment by Region
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Abbott Laboratories Inc.
• Allergan PLC
• Eli Lilly and Co.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Macleods Pharmaceuticals Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis International AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Arti Sharma
Phone 07803040404
Business Address 305-308, Commerce House, Janjeerwala Square
Country India
Categories Health , Medical , Research
Tags healthcare , market forecast , market research , medical devices , pharmaceutical
Last Updated March 11, 2020